|
2026
|
Invention
|
Subcutaneous formulations of anti-cd38 antibodies and their uses.
The present invention relates ... |
|
|
Invention
|
Calr and jak2 t-cell receptors.
Described herein are T-cell receptors (TCRs) that bind to CALR o... |
|
|
Invention
|
Methods for treatment of bladder cancer with gemcitabine.
Drug delivery devices and methods are ... |
|
|
Invention
|
Prostate neoantigens and their uses.
The disclosure relates to prostate neoantigens, polynucleot... |
|
|
Invention
|
Methods for lowering blood glucose.
The present invention provides a method for lowering blood g... |
|
|
Invention
|
Therapies with 3rd generation egfr tyrosine kinase inhibitors.
The present invention relates to ... |
|
|
Invention
|
Methods for production of radioimmunoconjugates. The disclosure provided herein relates to the fi... |
|
|
Invention
|
Cd8a-binding fibronectin type iii domains.
Fibronectin type III domains (FN3) that specifically ... |
|
|
Invention
|
Combination therapies comprising daratumumab, bortezomib, thalidomide and dexamethasone and their... |
|
|
Invention
|
Anti-cd38 antibodies for treatment of light chain amyloidosis and other cd38-positive hematologic... |
|
|
Invention
|
Bispecific anti-egfr/c-met antibody-drug conjugates.
This disclosure relates to bispecific anti-... |
|
|
Invention
|
Bispecific anti-egfr/c-met antibody-drug conjugates. This disclosure relates to bispecific anti-E... |
|
|
Invention
|
Enozertinib for treating epidermal growth factor receptor (egfr) exon 20 mutant nsclc in combinat... |
|
|
Invention
|
Clinically proven subcutaneous pharmaceutical compositions comprising anti-cd38 antibodies and th... |
|
|
Invention
|
Materials and methods for viral engineering. The present invention provides materials and methods... |
|
2025
|
Invention
|
T cell-specific promoters and methods of use. Compositions and methods for specific expression of... |
|
|
Invention
|
Methods of treating atopic dermatitis with multispecific antibodies having specificity for il4r-a... |
|
|
Invention
|
Proteins comprising kallikrein related peptidase 2 antigen binding domains and their uses.
Embod... |
|
|
Invention
|
Materials, methods and systems for stimulating host immune responses. The present disclosure rela... |
|
|
Invention
|
Methods of treating high risk multiple myeloma.
Disclosed are methods of treating a subject havi... |
|
|
Invention
|
Combination treatment of prostate cancer. Compositions and methods for the treatment of cancer, i... |
|
|
Invention
|
Bcma-targeted car-t cell therapy of multiple myeloma.
Provided herein is a method of treating a ... |
|
|
Invention
|
Bispecific egfr/c-met antibodies.
Bispecific EGFR/c-Met antibodies and methods of making and usi... |
|
|
Invention
|
Methods and compositions for modulating beta chain mediated immunity.
Anti-Vβ17 antibodies or an... |
|
|
Invention
|
Methods and systems for enhanced multispecific metabolic and cellular targeting. Materials, metho... |
|
|
Invention
|
Methods of treating smoldering multiple myeloma with ciltacabtagene autoleucel. Provided herein a... |
|
|
Invention
|
Materials, methods, and systems for biologic molecule occupancy determinations. Materials, method... |
|
|
Invention
|
Gemcitabine for use in methods of treating high-risk non-muscle invasive bladder cancer unrespons... |
|
|
Invention
|
Combination of trispecific antibody targeting bcma, gprc5d and cd3, and an anti-cd38 antibody for... |
|
|
Invention
|
Methods of treating bacillus calmette-guérin (bcg)-naïve high-risk non-muscle invasive bladder ca... |
|
|
Invention
|
Bcma-targeted car-t cell therapy for multiple myeloma.
Provided herein is a method of treating a... |
|
|
Invention
|
Molecules that bind to mutant calreticulin and uses thereof.
The present disclosure relates to a... |
|
|
Invention
|
Doses and pharmaceutical compositions of a cd33 x vd2 bispecific antibody for the treatment of ca... |
|
|
Invention
|
Gprc5d antibodies with enhanced effector function and uses thereof.
Herein are antibodies or ant... |
|
|
Invention
|
Methods of treating ulcerative colitis with anti-il23 specific antibody.
A method of treating ul... |
|
|
Invention
|
Methods of treating crohn's disease with anti-il23 specific antibody.
A method of treating Crohn... |
|
|
Invention
|
Syringe accessory |
|
|
Invention
|
Compositions and methods for the treatment of prostate cancer.
Compositions and methods for the ... |
|
2024
|
Invention
|
Devices and methods for delivering a drug via an api-loaded tissue penetrator.
A drug delivery d... |
|
2023
|
Invention
|
High concentration bispecific antibody formulations.
Provided herein are stable aqueous pharmace... |
|
|
Invention
|
Ocular needle guide and method to facilitate access to an eye.
An ocular needle guide for access... |
|
2022
|
Invention
|
Materials and methods for improved expansion and uses of immune cells.
Provided herein are, inte... |
|
2021
|
Invention
|
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases. The p... |
|
2019
|
P/S
|
Operating an online-marketplace featuring cell and gene therapy treatments and services; business... |
|
2014
|
Invention
|
Sc-β cells and compositions and methods for generating the same. Disclosed herein are methods, co... |
|
2008
|
P/S
|
Pharmaceutical and veterinary preparations, pharmaceutical preparations for the prevention and tr... |
|
2007
|
P/S
|
patient assistance program, namely, financial assistance for patients receiving pharmaceutical pr... |
|
2003
|
P/S
|
Pharmaceutical for the treatment of autoimmune diseases and autoimmune disorders. |
|
2002
|
P/S
|
pharmaceutical preparations for the treatment of autoimmune diseases and autoimmune disorders |
|
2001
|
P/S
|
Medical device used to infuse pharmaceuticals. |
|
|
P/S
|
Pharmaceutical for treatment of autoimmune diseases and disorders. |
|
1998
|
P/S
|
Pharmaceutical and medical preparations and substances; pharmaceutical compositions for the treat... |
|
|
P/S
|
Pharmaceutical compositions for treatment of autoimmune diseases and disorders. |
|
|
P/S
|
Pharmaceutical compositions for treatment of autoimmune diseases and disorders |
|
1996
|
P/S
|
Pharmaceutical preparations and products. |
|
1994
|
P/S
|
Pharmaceutical preparations for prevention and treatment of disease of the circulatory system. |
|
|
P/S
|
pharmaceutical preparations for the prevention and treatment of diseases of the circulatory system |
